The Serum Levels of Eosinophil Cationic Protein (ECP) Are Related to the Infiltration of Eosinophils in the Tumours of Patients with Hodgkin's Disease

References

• Landis S, Murray H., Bolden T. S, Wingo P A. Cancer statistics 1998. CA Cancer J Clin 1998; 48: 6
   PubMed Web of Science ®Google Scholar
• Henry-Amar Joly M. F. Late complications after Hodgkin's disease. Ann Oncol 1996; 7: 115
   PubMed Web of Science ®Google Scholar
• Enblad Sundström G., Glimelius C. B. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Haematol Oncol 1993; 11: 187
   PubMed Web of Science ®Google Scholar
• Tóth J. Dworák, Sugá O., Ar J. Eosinophil predominance in Hodgkin's disease. Z Krebsforsch 1977; 89: 107
   Google Scholar
• von Wasielewski Seth R., Franklin S., Fischer J., Httbner R., Hansmann M., Diehl L. M, Georgii V. A. Tissue eosinophilia correlates strongly with poor prognosis in nodularclerosing Hodgkin's disease, allowing for known prognostic factors. Blood 2000; 95: 1207
   PubMed Web of Science ®Google Scholar
• Spry C. Eosinophils. A comprehensive review, and guide to the scientific and medical literature. Oxford University Press. 1988
   Google Scholar
• Endo Usuki M., Kitazume K., Iwabe K., Okuyama K., Urabe Y. A. Hypereosinopbilic syndrome in Hodgkin's disease with increased granulocyte-macrophage colony-stimulating factor. Ann Hematol 1995; 71: 313
   PubMed Web of Science ®Google Scholar
• Teruya-Feldstein J. Jaffe, Burd S. E, Kingma R. P, Setsuda W. D, Tosatu E. JG. Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 1999; 93: 2463
   PubMed Web of Science ®Google Scholar
• Jundt Anagnostopoulos F., Bommert I., Emmerich K., Muller F., Foss G. H-D, Royer H-D, Stein H., Dörken B. Hodgkin/Reed-Stemberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 1999; 94: 2065
   PubMed Web of Science ®Google Scholar
• Trulson Nilsson A., Venge S. P. The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer. Br J Haematol 1997; 98: 312
   PubMed Web of Science ®Google Scholar
• Frandsen Lose B. G. Determination of eosinophil cationic protein in urine by an immunoassay. Scand J Clin Lab Invest 1986; 46: 629
   PubMed Web of Science ®Google Scholar
• Virchow J C, Jr, Holscher Virchow Sr U. C. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis 1992; 146: 604
   PubMed Web of Science ®Google Scholar
• Harris N, Jatte L., Stein S. E, Banks H., Chan M. P, Cleary K. J, Delsol L. M, De Wolf-Peeters G., Falini C. B, Gatter K C. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361
   PubMed Web of Science ®Google Scholar
• Carbone P, Kaplan P., Musshoff S. H, Smithers K., Tubiana W. DM. Report on the committee on Hodgkin's disease staging. Cancer Res 1971; 31: 1960
   Google Scholar
• Glimelius Enblad B., Kälkner G., Gustavsson M., Jakobsson A., Branehög M., Lennero I., Bj P., Urkhohn M. Treatment of Hodgkin's disease: The Swedish National Care Programme Experience. Leuk Lymphoma 1996; 21: 71
   PubMed Web of Science ®Google Scholar
• Peterson C, Enander G., Nystrand I., Anderson J., Nilsson S. A, Venge L. P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991; 21: 561
   PubMed Web of Science ®Google Scholar
• Tai Po-Chun Spry Peterson C., Venge C., Olsson P. I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984; 309: 182
   PubMed Web of Science ®Google Scholar
• Cordell J, Falini L., Erber B., Ghosh N. W, Abdulaziz K. A, Mac Donald Z., Pulford S., Stein A. KH., Mason D Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219
   PubMed Web of Science ®Google Scholar
• Tesch Feller H., Jucker C. A, Klein M., Meoz S., Diehl H. V. Activation of cytokines in HD. Ann Oncol 1991; 3: 13
   Google Scholar
• Desenne J, Acquatella J., Stern G., Muller R., Sanchez A., Somoza M. R. Blood eosinophilia in Hodgkin's disease. A follow-up of 25 cases in Venezuela. Cancer 1992; 69: 1248
   PubMed Web of Science ®Google Scholar
• Vaughan Hudson Linch B., Macintyre C. D, Bennett A. E, Maclennan H. M, Vaughan A. K, Hudson G., Jelliffe A M. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease. J Clin Pathol 1987; 40: 247
   PubMed Web of Science ®Google Scholar
• Macintyre E, Vaughan Hudson Hudson A., Vaughan B., Jelliffe G. AM, Linch D C. Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease. J Clin Pathol 1987; 40: 245
   PubMed Web of Science ®Google Scholar
• Pinto Aldinucci A., Gloghini D., Zagonel A., Degan V., Improta M., Juzbasic S., Todesco S., Perin M., Gattei V., Herrmann V., Grass F. H-J, Carbone A. Human eosinophils express functional CD 30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood 1996; 88: 3299
   PubMed Web of Science ®Google Scholar
• Wendtner C, Schmitt M., Gruss B., Druker J. H, Emmerich J. B, Goodwin B., Hallek G. RM. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line. Cancer Res 1995; 55: 4157
   PubMed Web of Science ®Google Scholar
• Gruss H, Boiani J., Williams N., Armitage E. D, Smith J. RCA., Goodwin R G. Pleiotropic effects of the CD 30 ligand on the CD 30-expressing cells and lymphoma cell lines. Blood 1994; 83: 2045
   PubMed Web of Science ®Google Scholar
• Gruss H, Da Silva J., Hu N., Uphoff B. Z, Goodwin C. CRG., Drexler H G. Expression and regulation of CD 30 ligand and CD 30 in human leukemia-lymphoma cell lines. Leukemia 1994; 8: 2083
   PubMed Web of Science ®Google Scholar
• Gruss H, Ulrich J., Braddy D., Armitage S. RJ, Dower S K. Recombinant CD 30 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur J Immunol 1995; 25: 2083
   PubMed Web of Science ®Google Scholar
• Samoszuk Nansen M. L. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990; 75: 13
   PubMed Web of Science ®Google Scholar
• Fuggle W, Crocker J. J, Smith P J. A quantitative study of eosinophil polymorphs in Hodgkin's disease. J. Clin Pathol 1984; 37: 267
   PubMed Web of Science ®Google Scholar
• Specht Lauritzen L., Nordentoft F. A, Andersen M. A, Christensen K. P, Hippe E. B, Hou E., Jensen K., Nissen N I. Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease. Cancer 1990; 65: 2594
   PubMed Web of Science ®Google Scholar
• Newcom S, Tagra R. KK, Kadin M E. Neutralizing antibodies against transferring growth factor β potentiate the proliferation of ki-1 positive lymphoma cells. Am J Pathol 1992; 140: 709
   PubMed Web of Science ®Google Scholar
• Kadin Butmarc M., Elovic J., Wong A. D. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease. Am J Pathol 1993; 142: 11
   PubMed Web of Science ®Google Scholar
• Newcom Tagra S. K. High molecular weight transforming growth factor β is excreted in the urine in active nodular sclerosing Hodgkin's disease. Cancer Res 1992; 52: 6768
   PubMed Web of Science ®Google Scholar
• Hernäs Särnstrand J., Lindroth B., Peterson P., Venge P.C.G., Malmstrom P. A. Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. Eur J Cell Biol 1992; 59: 352
   PubMed Web of Science ®Google Scholar